Medication deliver to eligible pts in real world is a challenge while the dose-titration and optimization to goal doses used in clinical trials is yet another one.
Despite multiple studies showing cost-effectiveness of HF medications across many parts of the world, the probelem with medication utilization and dose optimization continues to persist. This not only limits the true benefits of the medicine but also without goal doses that have demonstrated benefit in clinical trials, we are not sure what we are achieving even if pts are on those medications.
What is the authors take, being experts in this field, on bridging the gap between trial world and the real world. What measures can we as general practitioners or advance cardiology providers implement?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.